Anesthesia Gases Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 4.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Anesthesia Gases Market Analysis
The Global Anesthesia Gases Market is expected to register a CAGR of 4% during the forecast period.
The increasing geriatric population who are prone to chronic diseases and the rising number of emergency cases are actively affecting the growth of the market studied as they need surgical interventions using anesthesia. According to the British Heart Foundation Factsheet, published in August 2022, about 7.6 million people in the United Kingdom had heart or circulatory diseases in 2022. As per the same source, it was observed that over half of the UK population is expected to experience a heart or circulatory condition during their lifetime. Notably, the number of individuals living with heart and circulatory diseases in the United Kingdom surpasses the combined count of those affected by cancer and Alzheimer's. Hence, the high number of patients suffering from cardiac diseases requiring cardiac surgeries is anticipated to fuel the demand for anesthesia gases in the market over the forecast period.
Furthermore, a significant increase in sports-related injuries, spinal cord injuries (SCI), and accidental fractures has driven the demand for surgical procedures, consequently boosting the utilization of anesthesia gases. For instance, according to the National Spinal Cord Injury Statistical Center report, in 2022, the annual incidence of traumatic spinal cord injury (SCI) was approximately 54 cases per one million people in the United States, which equals about 18,000 new SCI cases each year. The estimated number of people with SCI living in the United States last year was approximately 299,000, ranging from 253,000 to 378,000 persons. Thus, the high prevalence of sports-related injuries is expected to increase the demand for surgical procedures, boosting the usage of anesthesia gases.
Furthermore, increasing product recommendations and government acceptance of anesthesia gas usage are likely to boost the market growth. For instance, in November 2023, Sedana Medical AB stated that the European Medicines Agency's Paediatric Committee endorsed the company's Paediatric Investigation Plan, securing data exclusivity and market protection for Sedana Medical's Sedaconda (isoflurane) until 2031.
Therefore, with the rising prevalence of chronic diseases, rising surgical procedures, and product launches by key market players, the market studied is anticipated to grow over the analysis period. However, increasing generic anesthesia usage and side effects of anesthesia gases are expected to impede market growth over the forecast period.
Anesthesia Gases Market Trends
Isoflurane Gas is Expected to Witness Significant Growth During the Forecast Period
Isoflurane is commonly used for the induction and maintenance of general anesthesia in the operating room. The increasing number of emergency departments, surgical interventions, and the rising geriatric population prone to chronic diseases are expected to drive the segment growth.
Due to the widespread applications and safety of isoflurane, its usage is likely to increase, which is expected to drive the segment growth over the study period. For instance, according to an article updated by NCBI in August 2022, isoflurane is a volatile anesthetic gas approved by the FDA for the induction and maintenance of general anesthesia. Unlike other common anesthesia gases, isoflurane is non-flammable. The source also stated that regarding cardiac function, isoflurane has minimal impact on left ventricular function. Still, it does cause a dose-dependent decrease in systemic vascular resistance due to mild beta-adrenergic stimulation. Thus, the increasing advantages of isoflurane are expected to boost its adoption during surgical procedures, propelling segment growth.
Companies offering anesthesia gas products are innovating, launching new products, and expanding their capabilities to fuel the availability of many anesthesia gases in the market, thus boosting segment growth over the study period. For instance, in October 2023, Sedana Medical received marketing authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA) for Sedaconda (isoflurane) in the United Kingdom. In addition, as per the quarterly report of Piramal Pharma Limited in 2024, the company planned to expand its inhalation isoflurane anesthesia facility in India. These new product approvals and facility expansion are expected to increase the availability of anesthesia gas products, thereby driving market growth over the forecast period.
Thus, the adoption of isoflurane gas, coupled with new product approvals, is expected to increase during the forecast period due to its growing usage in surgeries and company activities such as product launches globally.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is likely to have a significant share of the overall market owing to the region's rising geriatric population and increased surgical procedures. According to the National Spinal Cord Injury Statistical Center, in 2022, about 30% of the patients with spinal cord injury (SCI) were re-hospitalized one or more times during any given year following injury. Among those re-hospitalized, the length of hospital stay averaged about 18 days in the United States. Hence, due to the rising number of spinal cord injuries in the United States, spinal cord surgeries are also expected to increase, leading to increased usage of anesthesia gases.
Moreover, the rising incidence of spinal cord injuries in Canada may increase the need for more surgical interventions using anesthesia and is expected to enhance the market growth in the region. For instance, according to an article published by Frontiers in November 2022, it is estimated that in Canada, more than 86,000 people are affected by spinal cord injuries every year, from either a traumatic or non-traumatic injury.
Furthermore, anesthesia gas manufacturing companies are expanding their facilities to meet high demand, which is expected to propel the market growth. For instance, as per the quarterly report of Piramal Pharma Limited in 2024, the company planned to expand its inhalation sevoflurane and desflurane anesthesia facility in the United States. Thus, the establishment of the new facility helps provide anesthesia gases to address the growing demand in the country, thereby boosting the market growth in the region.
Therefore, owing to the factors mentioned above, such as the rising geriatric population and increased surgical procedures, the market studied is anticipated to flourish in North America.
Anesthesia Gases Industry Overview
The anesthesia gas market is fragmented due to the presence of many companies. The competitive landscape highlights key international and local players renowned for their substantial market shares. Various market players are involved in new product launches and expanding their offerings to various countries, which increases the availability of anesthesia gas globally. Some of the companies operating in the market include AbbVie Inc., Baxter, Drägerwerk AG & Co. KGaA, Fresenius SE & Co. KGaA, GE Healthcare, Mindray Medical International Limited, and Piramal Enterprise Ltd.
Anesthesia Gases Market Leaders
-
AbbVie Inc.
-
Baxter
-
Fresenius SE & Co. KGaA
-
Drägerwerk AG & Co. KGaA
-
GE Healthcare
*Disclaimer: Major Players sorted in no particular order
Anesthesia Gases Market News
- March 2024: The Directorate General of Health Services, India, instructed public and private hospitals to use isoflurane or sevoflurane instead of halothane as inhalational anesthetics in operation theatres to prevent anesthesia-related accidents.
- December 2023: Sedana Medical AB filed a type II variation to expand the existing Sedaconda (isoflurane) indication in Europe. The proposed expansion aims to encompass the pediatric population, specifically targeting ages 3 to 17, for inhaled sedation during mechanical ventilation.
Anesthesia Gases Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Geriatric Population Prone To Chronic Diseases
- 4.2.2 Increasing Number of Emergency Cases
-
4.3 Market Restraints
- 4.3.1 Increasing Generic Anesthesia Usage
- 4.3.2 Side Effects of Anesthesia Gases
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Product Type
- 5.1.1 Anesthesia Gases
- 5.1.1.1 Desflurane
- 5.1.1.2 Sevoflurane
- 5.1.1.3 Isoflurane
- 5.1.1.4 Nitrous Oxide
- 5.1.1.5 Other Anesthesia Gases
- 5.1.2 Vaporizer Devices
-
5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Ambulatory Surgery Centers
- 5.2.3 Others
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 AbbVie Inc.
- 6.1.2 Baxter International Inc.
- 6.1.3 Dragerwerk AG & Co. KGaA
- 6.1.4 Fresenius SE & Co. KGaA
- 6.1.5 GE Healthcare
- 6.1.6 Mindray Medical International Limited
- 6.1.7 BPL Group (Penlon)
- 6.1.8 MSS International Ltd
- 6.1.9 OES Medical
- 6.1.10 Piramal Enterprise Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAnesthesia Gases Industry Segmentation
As per the report's scope, anesthesia gases are used for the induction and maintenance of general anesthesia and sedation. The most common anesthesia gases are sevoflurane, desflurane, and nitrous oxide.
The anesthesia gas market is segmented by product type, end user, and geography. By product type, the market is segmented into anesthesia gases and vaporizer devices. The anesthesia gases segment is sub-segmented into desflurane, sevoflurane, isoflurane, nitrous oxide, and other anesthesia gases. By end user, the market is segmented into hospitals, ambulatory surgery centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers market sizes and forecasts in terms of value (USD) for the above segments.
| By Product Type | Anesthesia Gases | Desflurane |
| Sevoflurane | ||
| Isoflurane | ||
| Nitrous Oxide | ||
| Other Anesthesia Gases | ||
| By Product Type | Vaporizer Devices | |
| By End User | Hospitals | |
| Ambulatory Surgery Centers | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Anesthesia Gases Market Research FAQs
What is the current Global Anesthesia Gases Market size?
The Global Anesthesia Gases Market is projected to register a CAGR of 4% during the forecast period (2024-2029)
Who are the key players in Global Anesthesia Gases Market?
AbbVie Inc., Baxter, Fresenius SE & Co. KGaA, Drägerwerk AG & Co. KGaA and GE Healthcare are the major companies operating in the Global Anesthesia Gases Market.
Which is the fastest growing region in Global Anesthesia Gases Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Anesthesia Gases Market?
In 2024, the North America accounts for the largest market share in Global Anesthesia Gases Market.
What years does this Global Anesthesia Gases Market cover?
The report covers the Global Anesthesia Gases Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Anesthesia Gases Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Needles Industry Report
Statistics for the 2024 Needles market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Needles analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
